Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study

Kwadwo A Koram, Bright Adu, Josephine Ocran, Yaa S Karikari, Susan Adu-Amankwah, Michael Ntiri, Benjamin Abuaku, Daniel Dodoo, Ben Gyan, Karl C Kronmann and Francis Nkrumah

PLOS ONE, 2016, vol. 11, issue 9, 1-18

Abstract: Trial registration: ClinicalTrials.gov. Identifier: NCT01026246

Date: 2016
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0163066 (text/html)
https://journals.plos.org/plosone/article/file?id= ... 63066&type=printable (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:plo:pone00:0163066

DOI: 10.1371/journal.pone.0163066

Access Statistics for this article

More articles in PLOS ONE from Public Library of Science
Bibliographic data for series maintained by plosone ().